Sedentarismo, sobrepeso e microbiota intestinal: risco aumentado de diabetes mellitus tipo II em mulheres com ovários policísticos

Luciano Henrique Pinto; Daniela Delwing de Lima; Jordany Bosse Lorenzi; Fernanda Leonardi Giaretta; Déborah Vanessa Giaretta; Beatriz  Bittencourt Massinhan

doi:10.36489/saudecoletiva.2023v13i88p13394-13394

Authors

Luciano Henrique Pinto Professor do Curso de Medicina, Coordenador do Projeto Integrado ECOSAM Universidade da Região de Joinville – UNIVILLE.
Daniela Delwing de Lima Professora do Curso de Medicina.
Jordany Bosse Lorenzi Graduanda em Medicina.
Fernanda Leonardi Giaretta Graduanda em Medicina.
Déborah Vanessa Giaretta Graduanda em Medicina.
Beatriz Bittencourt Massinhan Bolsistas de Pesquisa Projeto ECOSAM, graduandas em Medicina.

DOI:

https://doi.org/10.36489/saudecoletiva.2023v13i88p13394-13394

Keywords:

Polycystic Ovary Syndrome; Diabetes; Overweight

Abstract

Objective: To evaluate the influence of a sedentary lifestyle and overweight on the precocity of Type 2 Diabetes mellitus (DM II) in women with Polycystic Ovary Syndrome (PCOS). Method: observational pilot study, document analysis and interviews developed via the GoogleForms® platform with 42 women with PCOS aged between 21 and 45 years, with and without a diagnosis of DM II. Results: 42 women took part in the study, 23 diabetics and 19 non-diabetics. Women who spend more time in front of the television or using their cell phones can increase the risk of obesity by up to 23% and of Diabetes mellitus 2 in women with Polycystic Ovary Syndrome by up to 14%. Conclusion: the practice of physical activity has not been shown to be sufficient to reduce BMI, with overweight being a common characteristic in women with PCOS without DM and with DM II. Therefore, weight control needs to be better explained to the group.

References

Palioura E, Diamanti-Kandarakis E. Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs). Rev Endocr Metab Disord 2015; 16: 365–371.

Hoeger KM, Dokras A, Piltonen T. Update on PCOS: Consequences, Challenges, and Guiding Treatment. The Journal of Clinical Endocrinology & Metabolism 2021; 106: e1071–e1083.

Moghetti P, Tosi F. Insulin resistance and PCOS: chicken or egg? J Endocrinol Invest 2021; 44: 233–244.

Magliano DJ, Sacre JW, Harding JL, et al. Young-onset type 2 diabetes mellitus — implications for morbidity and mortality.

Nat Rev Endocrinol 2020; 16: 321–331.

Nolan CJ, Prentki M. Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shift. Diabetes and Vascular Disease Research 2019; 16: 118–127.

Sampath Kumar A, Maiya AG, Shastry BA, et al. Exercise and insulin resistance in type 2 diabetes mellitus: A systematic review and meta-analysis. Annals of Physical and Rehabilitation Medicine 2019; 62: 98–103.

Miot HA. Tamanho da amostra em estudos clínicos e experimentais. J vasc bras 2011; 10: 275–278.

Moghetti P. Insulin Resistance and Polycystic Ovary Syndrome. CPD 2016; 22: 5526–5534.

Elicker Rosin B, Reinert Avilla Machado F, Martina da Rosa S, et al. Influência dos fatores “sobrepeso” e “sedentarismo” no aparecimento precoce de diabetes em mulheres com SOP. SaudColetiv (Barueri) 2021; 11: 4676–4685.

Abdelbasset WK. Resistance Exercise Versus Aerobic Exercise Combined with Metformin Therapy in the Treatment of type 2 Diabetes: A 12-Week Comparative Clinical Study. EMIDDT 2021; 21: 1531–1536.

Holman GD. Structure, function and regulation of mammalian glucose transporters of the SLC2 family. Pflugers Arch - Eur J Physiol 2020; 472: 1155–1175.

Kakoly NS, Khomami MB, Joham AE, Cooray SD, Misso ML, Norman RJ, et al. Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: A systematic review and meta-regression. Hum Reprod Update. 2018 Jul 1;24(4):p.55–67.

Costa MF, Prado SD, Carvalho MC da VS. Orthorexia in social media: reflections between health and disease. Saúde Soc. [Internet]. 2022May16 [cited 2022Jun.18];31(2):e210760pt. Available from: https://www.revistas.usp.br/sausoc/article/ view/197852

Ahmadi S, Jamilian M., Karamali M., Tajabadi-Ebrahimi M., Jafari P, Taghizadeh M. et al. Probiotic supplementation and the effects on weight loss, glycemia and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Hum Fertil (Camb). 2017; 20(4):254-61.

Darvishi S, Rafraf M, Asghari-Jafarabadi M, Farzadi L. Synbiotic supplementation improves metabolic factors and obesity values in women with polycystic ovary syndrome independent of affecting apelin levels: a randomized double-blind placebo-controlled clinical trial. Int J Fertil Steril. 2021; 15(1):51-9.

Green, M., Arora, K., Prakash, S. Microbial Medicine: Prebiotic and Probiotic Functional Foods to Target Obesity and Metabolic Syndrome.Int. J. Mol. Sci. 2020 , 21 (8), 2890; https://doi.

org/10.3390/ijms21082890